ADHD Treatments, Sleep, and Sleep Problems: Complex Associations

被引：107
作者：
Stein, Mark A. [1 ]
Weiss, Margaret [2 ]
Hlavaty, Laura [1 ]
机构：
[1] Univ Illinois, Chicago, IL 60607 USA
[2] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
来源：
NEUROTHERAPEUTICS | 2012年 / 9卷 / 03期
关键词：
ADHD; Sleep; Psychopharmacology; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; METHYLPHENIDATE TRANSDERMAL SYSTEM; EXTENDED-RELEASE; DOUBLE-BLIND; LISDEXAMFETAMINE DIMESYLATE; ADVERSE EVENTS; PREPUBERTAL CHILDREN; OROS METHYLPHENIDATE; DISTURBANCES;
D O I：
10.1007/s13311-012-0130-0
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
ADHD, sleep, and ADHD treatments are highly interrelated. In this review, we describe the effects of stimulants and non stimulant medications on sleep in children, adolescents, and adults with ADHD. Clinical predictors of sleep problems during pharmacotherapy include age, sleep problems prior to initiating treatment, and dose and dosing schedule. As yet, we have little understanding of the biological or genetic factors related to individual variation in drug response and sleep.
引用
收藏
页码：509 / 517
页数：9
相关论文
共 66 条
  • [1] Associations Between Psychiatric Comorbidities and Sleep Disturbances in Children With Attention-Deficit/Hyperactivity Disorder
    Accardo, Jennifer A.
    Marcus, Carole L.
    Leonard, Mary B.
    Shults, Justine
    Meltzer, Lisa J.
    Elia, Josephine
    [J]. JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2012, 33 (02) : 97 - 105
  • [2] Adler Lenard A, 2009, J Clin Psychiatry, V70, pe12
  • [3] ATOMOXETINE TREATMENT IN ADULTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER AND COMORBID SOCIAL ANXIETY DISORDER
    Adler, Lenard A.
    Liebowitz, Michael
    Kronenberger, Williain
    Qiao, Meihua
    Rubin, Richard
    Hollandbeck, Millie
    Deldar, Ahmed
    Schuh, Kory
    Durell, Todd
    [J]. DEPRESSION AND ANXIETY, 2009, 26 (03) : 212 - 221
  • [4] AHMANN PA, 1993, PEDIATRICS, V91, P1101
  • [5] BARKLEY RA, 1990, PEDIATRICS, V86, P184
  • [6] Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: A double-blind, placebo-controlled, crossover analog classroom study
    Biederman, Joseph
    Boellner, Samuel W.
    Childress, Ann
    Lopez, Frank A.
    Krishnan, Suma
    Zhang, Yuxin
    [J]. BIOLOGICAL PSYCHIATRY, 2007, 62 (09) : 970 - 976
  • [7] Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study
    Biederman, Joseph
    Krishnan, Suma
    Zhang, Yuxin
    McGough, James J.
    Findling, Robert L.
    [J]. CLINICAL THERAPEUTICS, 2007, 29 (03) : 450 - 463
  • [8] Once-Daily Atomoxetine for Treating Pediatric Attention-Deficit/Hyperactivity Disorder: Comparison of Morning and Evening Dosing
    Block, Stan L.
    Kelsey, Douglas
    Coury, Daniel
    Lewis, Donald
    Quintana, Humberto
    Sutton, Virginia
    Schuh, Kory
    Allen, Albert J.
    Sumner, Calvin
    [J]. CLINICAL PEDIATRICS, 2009, 48 (07) : 723 - 733
  • [9] Effects of Open-Label Lisdexamfetamine Dimesylate on Self-Reported Quality of Life in Adults with ADHD
    Brams, Matthew
    Giblin, John
    Gasior, Maria
    Gao, Joseph
    Wigal, Timothy
    [J]. POSTGRADUATE MEDICINE, 2011, 123 (03) : 99 - 108
  • [10] THE EFFECTS OF NOCTURNALLY ADMINISTERED STIMULANT MEDICATION ON EEG SLEEP AND BEHAVIOR IN HYPERACTIVE-CHILDREN
    CHATOOR, I
    WELLS, KC
    CONNERS, CK
    SEIDEL, WT
    SHAW, D
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1983, 22 (04) : 337 - 342
1234567